Clinical Trials Browser

Phase 2 × Meningeal Carcinomatosis × pembrolizumab × Clear all

NCT04729348 2025-07-25

Pembrolizumab And Lenvatinib In Leptomeningeal Metastases

Phase 2 Terminated

Meningeal Carcinomatosis